These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29459169)

  • 1. Update on the management of vasoproliferative tumour.
    Temblador-Barba I; Delgado-Alonso EM; Toribio-García M; Martínez-Campillo L; Molina-Leyva I; Martínez-Jiménez M
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Jul; 93(7):350-353. PubMed ID: 29459169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal dexamethasone implant (Ozurdex) and photodynamic therapy for vasoproliferative retinal tumours.
    Cebeci Z; Oray M; Tuncer S; Tugal Tutkun I; Kir N
    Can J Ophthalmol; 2014 Aug; 49(4):e83-4. PubMed ID: 25103664
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of vasoproliferative tumors of the retina].
    Li J; Cheng Y; Deng X; Meng QY; Liang JH
    Zhonghua Yan Ke Za Zhi; 2020 Apr; 56(4):272-278. PubMed ID: 32306619
    [No Abstract]   [Full Text] [Related]  

  • 4. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.
    Bakri SJ; Couch SM; McCannel CA; Edwards AO
    Retina; 2009 May; 29(5):573-8. PubMed ID: 19430278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
    Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
    Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel-Lindau disease.
    Tsai FY; Lau LI; Chen SJ; Lee FL; Lee SM
    J Chin Med Assoc; 2014 Jan; 77(1):52-6. PubMed ID: 24206762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
    Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
    Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
    Saito W; Kase S; Ohgami K; Mori S; Ohno S
    Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.
    Gado AS; Macky TA
    Clin Exp Ophthalmol; 2014; 42(7):650-5. PubMed ID: 24612095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surprises during intravitreal drug delivery-a report of three cases.
    Venkatesh P; Chawla R; Shah B; Garg SP
    Digit J Ophthalmol; 2017; 23(1):33-35. PubMed ID: 28924419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
    Kumar K; Raj P; Chandnani N; Agarwal A
    Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
    Kwon HJ; Kim M; Lee CS; Lee SC
    Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab and bevacizumab in combination with full-fluence verteporfin therapy and dexamethasone for exudative age-related macular degeneration.
    Forte R; Bonavolontà P; Benayoun Y; Adenis JP; Robert PY
    Ophthalmic Res; 2011; 45(3):129-34. PubMed ID: 20847575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
    Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
    Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.